AAV-PR rep/cap Citations (1)
Originally described in: An engineered AAV capsid mediates efficient transduction of pericytes and smooth muscle cells of the brain vasculature.Ramirez SH, Hale J, McCarthy S, Cardenas CL, Dona K, Hanlon KS, Hudry E, De La Cruz D, Ng C, Das S, Nguyen DM, Nammour J, Bennett RE, Andrews A, Musolino PL, Maguire CA Hum Gene Ther. 2023 Jun 27. doi: 10.1089/hum.2022.211. PubMed Journal
Articles Citing AAV-PR rep/cap
| Articles |
|---|
Treatment of a severe vascular disease using a bespoke CRISPR-Cas9 base editor in mice.
Alves CRR, Das S, Krishnan V, Ha LL, Fox LR, Stutzman HE, Shamber CE, Kalailingam P, McCarthy S, Lino Cardenas CL, Fong CE, Imai T, Mitra S, Yun S, Wood RK, Benning FMC, Roh K, Lawton J, Kim N, Silverstein RA, Ferreira da Silva J, de la Cruz D, Richa R, Xie J, Gray-Edwards HL, Malhotra R, Chung DY, Chao LH, Tsai SQ, Maguire CA, Lindsay ME, Kleinstiver BP, Musolino PL.
Nat Biomed Eng. 2025 Sep 11:10.1038/s41551-025-01499-1. doi: 10.1038/s41551-025-01499-1.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.